Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Johnson & Johnson - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
JNJ
New York
2830
www.jnj.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Johnson & Johnson
With uncertainty roiling Big Pharma, execs are placing lower-risk bets
- Feb 6th, 2025 10:07 am
Surging dollar spurs jump in corporate FX hedging
- Feb 6th, 2025 6:08 am
Steady M&A Deals to Begin 2025, Disappointing IPOs So Far
- Feb 5th, 2025 2:59 pm
Starboard Launches Proxy Fight at Kenvue
- Feb 5th, 2025 2:06 pm
This Johnson & Johnson Insider Reduced Their Stake By 37%
- Feb 5th, 2025 1:00 pm
CHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's Imfinzi
- Feb 4th, 2025 4:07 pm
Why Johnson & Johnson (JNJ) Is One of the Best Cancer Stock to Buy According to Hedge Funds
- Feb 3rd, 2025 1:02 pm
ViiV Healthcare and J&J’s adolescent HIV-1 combo gains EC authorisation
- Feb 3rd, 2025 9:30 am
The Zacks Analyst Blog Highlights NVIDIA, Johnson & Johnson, T-Mobile US and The Eastern
- Feb 3rd, 2025 9:30 am
Hospitals seek to intervene in J&J lawsuit against HHS to protect valuable drug discounts
- Feb 3rd, 2025 8:50 am
Is Johnson & Johnson (JNJ) the Most Promising Dividend Stock According to Hedge Funds?
- Feb 2nd, 2025 7:23 pm
Is Johnson & Johnson Stock a Buy?
- Feb 2nd, 2025 5:21 pm
Is Johnson & Johnson (JNJ) the Best Defensive Stock to Buy Right Now?
- Feb 1st, 2025 1:34 pm
Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock's Fortunes Around?
- Feb 1st, 2025 12:30 pm
Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock?
- Feb 1st, 2025 11:14 am
Why Johnson & Johnson (JNJ) Is Among the Best Long Term Low Risk Stocks to Buy Now
- Feb 1st, 2025 8:34 am
Top Research Reports for NVIDIA, Johnson & Johnson and T-Mobile
- Jan 31st, 2025 10:33 pm
US government could seek over $1 billion from J&J for cancer treatment costs
- Jan 31st, 2025 10:12 pm
Johnson & Johnson (NYSE:JNJ) Posts Q4 Sales In Line With Estimates
- Jan 31st, 2025 7:23 pm
Judge dismisses 2 counts in J&J pharmacy benefits lawsuit over upcharged drugs
- Jan 30th, 2025 5:18 pm
Scroll